The Canary Foundation is a non-profit organization dedicated to discovering highly sensitive and specific biomarkers of early stage cancer and building tests for these markers.
[1] The research goal is to be able to identify cancer through a simple blood test, soon after its development, so that treatment has a higher chance of success.
It was founded in 2004 by former Cisco Systems executive vice president Don Listwin.
In June 2009, the Canary Foundation, together with Stanford University, committed $20 million to the creation of a research center dedicated to improving cancer early detection.
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.